Azacitidine Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Azacitidine Injection (injection) from Bristol Myers Squibb Co. with status Current. The shortage was first posted on 12/18/2020.
Shortage Details
- Status
- Current
- Company
- Bristol Myers Squibb Co.
- Package NDC
- 59572-102-01
- Dosage Form
- Injection
- Presentation
- Vidaza, Injection, 100 mg (NDC 59572-102-01)
- Initial Posting
- 12/18/2020
- Revised Date